The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...
Inventia Life Science, an innovator in 3D cell culture technologies, announces the launch of RASTRUMâ„¢ Allegro, a ...
CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat movement-related symptoms of Parkinson's disease, the drugmaker said on Tuesday.
Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...
Neurocrine's pipeline includes 12 clinical programs, with two Phase 3 trials due to report in 2025. See why I rate NBIX stock ...